Announced Mon, 27 Apr · 22:05 IST

Gujarat Kidney And Super Speciality Limited has informed the Exchange about General Updates regarding approval for incorporation of wholly owned subsidiary

Management Changes View source PDF

GKSL · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+3.4%1-day move
₹114.50
prior close
₹114.98
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.9+1.2+0.7-0.1+3.4+7.1+9.2+7.6+7.9+22.2+22.2+19.9+13.5
Up moveDown movePending
AI summary

Gujarat Kidney And Super Speciality Limited announced outcomes from its Board meeting on April 27, 2026. The company appointed Ms. Vishakha Mahesh Phadke as Company Secretary and Compliance Officer. It also approved the incorporation of a Wholly Owned Subsidiary (WOS) to expand healthcare services in Bharuch, Gujarat - this was already approved by shareholders via Postal Ballot on April 25, 2026. The WOS will have initial capital of Rs 1 lakh and be 100% owned by the company. Additionally, shareholders approved interim fund utilization for healthcare expansion aligned with IPO objectives and voluntary revision of financial statements under Section 131 of the Companies Act, 2013.

Likely market impact

The WOS incorporation signals the company's expansion strategy into Bharuch district, which could drive future growth. However, the voluntary revision of financial statements warrants attention as it may indicate accounting adjustments. The appointment of a new Company Secretary strengthens compliance governance.